[Meeting Report] AMR Alliance Japan Symposium at the 94th Annual Meeting of the Japanese Association for Infectious Diseases, “The Actions Required of Us Right Now” (August 21, 2020)
date : 8/25/2020
Tags: AMR
On August 21, 2020, AMR Alliance Japan held a symposium as part of the 94th Annual Meeting of the Japanese Association for Infectious Diseases, entitled, “The Actions Required of Us Right Now.”
In addition to introducing the activities of AMR Alliance Japan, the symposium featured a panel of AMR Alliance Japan members, and highlighted the current actions that civil society, industry, and medical practitioners are all taking to prevent the spread of antimicrobial resistance (AMR).
Participants discussed priorities for future policy action, focusing on the topics of antimicrobial stewardship, education for the public and medical practitioners about AMR, incentive models to encourage R&D, and efforts to stabilize the supply of antimicrobials.
AMR refers to the phenomena by which bacteria become immune to antimicrobial treatments over time as those treatments are used more and more. Infectious diseases brought on by antimicrobial resistant bacteria can be difficult to treat, and can even be fatal in worst case scenarios.
It is estimated that as many as 8,000 people die every year of AMR-related causes in Japan. The problem of AMR is growing worse across the world. If current trends continue, it is projected that by 2050, as many as 10 million people could potentially die of AMR-related causes globally every year.
HGPI has taken a leading role in AMR policy within Japan as the secretariat of AMR Alliance Japan, which works with member Japanese medical societies, healthcare companies, and civil society organizations to develop and promote recommendations toward stronger AMR countermeasures. AMR Alliance Japan released broad-based recommendations for AMR policy in July 2019, and is currently actively working to realize those recommendations. More information on the Alliance and AMR can be found on the AMR Alliance Japan website at https://www.amralliancejapan.org/en/
■Program Outline
Meeting Introduction
Hiroshi Kiyota (President, Japanese Society of Chemotherapy / Professor, Department of Urology, The Jikei University Katsushika Medical Center)
Ryoji Noritake (CEO, Board Member, Health and Global Policy)
Presentation: AMR Alliance Japan’s Role and Future for the Advancement of AMR Policies
Ryoji Noritake (CEO, Board Member, Health and Global Policy)
Presentation: Initiatives of the Japan Pharmaceutical Manufacturers Association for AMR
Yasunori Tawaragi (Director, International Affairs, Japan Pharmaceutical Manufacturers Association)
Presentation: From the Perspective of Industry
Takuko Sawada (Director of the Board, Executive Vice President, Shionogi & Co., Ltd.)
Presentation: The Response to AMR by Medical Practitioners
Midori Hirai (Chair, Pharmaceutical Education Committee, The Pharmaceutical Society of Japan / Director, Japanese Red Cross Hyogo Blood Center)
Panel Discussion
Panelists:
Yasunori Tawaragi (Director, International Affairs, Japan Pharmaceutical Manufacturers Association)
Takuko Sawada (Director of the Board, Executive Vice President, Shionogi & Co., Ltd.)
Midori Hirai (Chair, Pharmaceutical Education Committee, The Pharmaceutical Society of Japan / Director, Japanese Red Cross Hyogo Blood Center)
Moderators:
Hiroshi Kiyota (President, Japanese Society of Chemotherapy / Professor, Department of Urology, The Jikei University Katsushika Medical Center)
Ryoji Noritake (CEO, Board Member, Health and Global Policy)
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)